Chemical formula: C₃₀H₃₂F₆N₄O Molecular mass: 578.603 g/mol PubChem compound: 6451149
There are no data about the use of netupitant in pregnant women. Studies in animals have shown reproductive toxicity including teratogenic effects in rabbit without safety margin.
It is unknown whether netupitant is excreted in human milk. A risk to the suckling child cannot be excluded. Netupitant capsules should not be used during breast-feeding. Breast-feeding should be discontinued during treatment with this medicinal product and for 1 month after the last dose.
Women of childbearing potential should not be pregnant or become pregnant while on treatment with netupitant. A pregnancy test should be performed on all pre-menopausal women prior to treatment. Women of childbearing potential must use effective contraception during therapy and up to one month after treatment with this medicinal product.
No effect on fertility has been observed in animal studies.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
